ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 770,95
0,48%
Dow Jones
43 990,19
1,16%
DAX
21 042,00
0,18%
Brent Oil
78,80
-0,53%
Bitcoin
107 090,01
4,96%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. BioCryst Pharmaceuticals Inc (BCRX) Cours

BioCryst Pharmaceuticals Inc

BioCryst Pharmaceuticals Inc (BCRX)

NASDAQ
7,595
0,145
( 1,95% )
Mis à jour : 21:12:31
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
7,595
Prix Achat
7,59
Prix Vente
7,60
Volume échangé
2 031 596
7,41 Fourchette du Jour 7,79
4,03 Plage de 52 semaines 8,88
Cap du marché
1,573B
Clôture Veille
7,45
Ouverture
7,48
Dernière Transaction
6
@
7.59
Dernière heure de transaction
21:13:22
Volume financier
US$ 15 581 560
VWAP
7,6696
Volume moyen (3 m)
2 224 574
Actions en circulation
207 132 571
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-7,03
Bénéfice par action (BPA)
-1,09
Chiffre d'affairess
331,41M
Bénéfice net
-226,54M

À propos de BioCryst Pharmaceuticals Inc

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, ... BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.biocryst.com
Siège social
Wilmington, Delaware, USA
Fondé
-
BioCryst Pharmaceuticals Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker BCRX. Le dernier cours de clôture d'BioCryst Pharmaceuticals était de US$7,45. Au cours de la dernière année, les actions de BioCryst Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 4,03 à US$ 8,88.

BioCryst Pharmaceuticals compte actuellement 207 132 571 actions en circulation. La capitalisation boursière d'BioCryst Pharmaceuticals est de US$1,54 milliard. BioCryst Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -7.03.

BCRX Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report

13 Janvier 2025
Edgar (US Regulatory)

Form 8-K - Current report

10 Janvier 2025
Edgar (US Regulatory)

BioCryst Announces Preliminary Full Year 2024 ORLADEYO® (berotralstat) Net Revenue of $437 Million (+34 percent y-o-y)

—ORLADEYO net revenue expected to be between $515-$535 million in 2025— —Total revenue (including RAPIVAB®) expected to be between $540-$560 million in 2025— —Company achieved operating profit in...

10 Janvier 2025
GlobeNewswire Inc.

Form 8-K - Current report

08 Janvier 2025
Edgar (US Regulatory)

BioCryst to Present at 43rd Annual J.P. Morgan Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the 43rd Annual J.P. Morgan...

07 Janvier 2025
GlobeNewswire Inc.

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

RESEARCH TRIANGLE PARK, N.C., Jan. 06, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors...

06 Janvier 2025
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

23 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

23 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

23 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

23 Décembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.375-4.705144291097.978.026.9628441717.26899331CS
4-0.135-1.746442432087.738.496.9621662837.61927981CS
12-0.515-6.350184956848.118.496.84522245747.56604172CS
260.3955.486111111117.28.886.4920837917.65402719CS
521.88533.01225919445.718.884.0327080196.4241134CS
156-6.105-44.562043795613.719.994.0330669838.95293023CS
2604.565150.6600660073.0319.991.5841544668.16131872CS

BCRX - Frequently Asked Questions (FAQ)

What is the current BioCryst Pharmaceuticals share price?
The current share price of BioCryst Pharmaceuticals is US$ 7,595
How many BioCryst Pharmaceuticals shares are in issue?
BioCryst Pharmaceuticals has 207 132 571 shares in issue
What is the market cap of BioCryst Pharmaceuticals?
The market capitalisation of BioCryst Pharmaceuticals is USD 1,54B
What is the 1 year trading range for BioCryst Pharmaceuticals share price?
BioCryst Pharmaceuticals has traded in the range of US$ 4,03 to US$ 8,88 during the past year
What is the PE ratio of BioCryst Pharmaceuticals?
The price to earnings ratio of BioCryst Pharmaceuticals is -7,03
What is the cash to sales ratio of BioCryst Pharmaceuticals?
The cash to sales ratio of BioCryst Pharmaceuticals is 4,81
What is the reporting currency for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals reports financial results in USD
What is the latest annual turnover for BioCryst Pharmaceuticals?
The latest annual turnover of BioCryst Pharmaceuticals is USD 331,41M
What is the latest annual profit for BioCryst Pharmaceuticals?
The latest annual profit of BioCryst Pharmaceuticals is USD -226,54M
What is the registered address of BioCryst Pharmaceuticals?
The registered address for BioCryst Pharmaceuticals is 2711 CENTERVILLE ROAD, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the BioCryst Pharmaceuticals website address?
The website address for BioCryst Pharmaceuticals is www.biocryst.com
Which industry sector does BioCryst Pharmaceuticals operate in?
BioCryst Pharmaceuticals operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ASSTAsset Entities Inc
US$ 0,8758
(88,55%)
251,56M
USEGUS Energy Corp
US$ 4,0977
(76,63%)
101,44M
SOPASociety Pass Inc
US$ 1,485
(66,91%)
2,95M
DWTXDogwood Therapeutics Inc
US$ 2,9996
(60,41%)
12,8M
DOGZDogness International Corporation
US$ 27,73
(53,20%)
1,75M
GOEVCanoo Inc
US$ 0,3504
(-74,04%)
37,88M
HEPAHepion Pharmaceuticals Inc
US$ 0,2826
(-39,74%)
1,02M
ORKTOrangeKloud Technology Inc
US$ 0,7301
(-34,81%)
6,8M
WNWMeiwu Technology Company Ltd
US$ 0,26
(-29,25%)
10,05M
FTAIFTAI Aviation Ltd
US$ 80,58
(-28,30%)
15,62M
GCTKGlucoTrack Inc
US$ 0,1226
(44,41%)
576,89M
CRKNCrown Electrokinetics Corporation
US$ 0,1175
(-6,00%)
369,39M
ASSTAsset Entities Inc
US$ 0,8758
(88,55%)
251,56M
RGTIRigetti Computing Inc
US$ 13,10
(33,27%)
197,15M
RIMEAlgorhythm Holdings Inc
US$ 0,0383
(-7,93%)
179,2M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
BCRX
BioCryst Pharmaceuticals
BIT
I06825
Intesa Sanpaolo
NASDAQ
FBYD
Falcons Beyond Global
BIT
F13737
Vontobel Financial Produ...
BIT
HYDE
Invesco Hydrogen Economy...
BIT
S32562
Societe Generale Effekten
BIT
P1N9M2
BNP Paribas Issuance
AQSE
MARU
Marula Mining
NASDAQ
PFEL
AXS 2X PFE Bull Daily ETF
LSE
AAEV
Albion Enterprise Vct
BIT
UC8MRZ
Unicredit Bank
BIT
STESS5
Societe Generale Effekten
BIT
SUST7S
Societe Generale Effekten
BIT
P1HL34
BNP Paribas Issuance BV
BIT
S32133
Societe Generale Effekten
AQSE
KING
Igraine
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés